Average Co-Inventor Count = 5.73
ph-index = 5
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Vtv Therapeutics LLC (17 from 52 patents)
2. High Point Pharmaceuticals, LLC (4 from 50 patents)
3. Bantam Pharmaceutical, LLC (1 from 7 patents)
22 patents:
1. 12091407 - Substituted fused imidazole derivatives, pharmaceutical compositions, and methods of use thereof
2. 11649230 - Substituted fused imidazole derivatives, pharmaceutical compositions, and methods of use thereof
3. 11325903 - Substituted pyrazole compounds and methods of using them for treatment of hyperproliferative diseases
4. 11130753 - Substituted fused imidazole derivatives, pharmaceutical compositions, and methods of use thereof
5. 10889580 - Substituted fused imidazole derivatives, pharmaceutical compositions, and methods of use thereof
6. 10570126 - Substituted fused imidazole derivatives, pharmaceutical compositions, and methods of use thereof
7. 10568888 - Tricyclic compounds as modulators of TNF-alpha synthesis and as PDE4 inhibitors
8. 10391097 - Tricyclic compounds as modulators of TNF-alpha synthesis and as PDE4 inhibitors
9. 10287284 - Substituted fused imidazole derivatives, pharmaceutical compositions, and methods of use thereof
10. 10085990 - Tricyclic compounds as modulators of TNF-α synthesis and as PDE4 inhibitors
11. 10030011 - Substituted fused imidazole derivatives, pharmaceutical compositions, and methods of use thereof
12. 9833457 - Tricyclic compounds as modulators of TNF-α synthesis and as PDE4 inhibitors
13. 9717710 - Treatment of mild and moderate Alzheimer's disease
14. 9707239 - Compounds that modulate oxidative stress
15. 9687489 - Tricyclic compounds as modulators of TNF-α synthesis and as PDE4 inhibitors